Monica Khunger

发表

A content analysis of smartphone-based applications for hypertension management.

Neetika Garg, Arjun Gupta, Nilay Kumar, 2015, Journal of the American Society of Hypertension : JASH.

Interaction of incidental microbleeds and prior use of antithrombotics with early hemorrhagic transformation: Causative or protective?

D. Liebeskind, B. Ouyang, K. Malhotra, 2016, Annals of Indian Academy of Neurology.

Novel EGFR Exon 18 (G721R) Mutation in a Patient with Non-Small Cell Lung Carcinoma with Lack of Response to Afatinib.

V. Velcheti, M. Abazeed, Monica Khunger, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Efficacy and Safety of Exercise Training in Chronic Pulmonary Hypertension: Systematic Review and Meta-Analysis

A. Pandey, J. Berry, Monica Khunger, 2015, Circulation. Heart failure.

Computer-extracted features relating to spatial arrangement of tumor infiltrating lymphocytes to predict response to nivolumab in non-small cell lung cancer (NSCLC).

A. Madabhushi, Xiangxue Wang, V. Velcheti, 2018 .

Computer extracted features of cancer nuclei from H&E stained tissues of tumor predicts response to nivolumab in non-small cell lung cancer.

A. Madabhushi, Xiangxue Wang, V. Velcheti, 2018 .

A Case of a Patient with Idiopathic Pulmonary Fibrosis with Lung Squamous Cell Carcinoma Treated with Nivolumab

V. Velcheti, Monica Khunger, 2017, Journal of Thoracic Oncology.

A case of crizotinib-induced esophageal ulcers.

V. Velcheti, Monica Khunger, T. Sussman, 2017, Lung cancer management.

Premature Clinical Trial Discontinuation in the Era of Immune Checkpoint Inhibitors.

M. Galsky, P. Grivas, S. Rakshit, 2018, The oncologist.

Correlation of radiomic features with PD-L1 expression in early stage non-small cell lung cancer (ES-NSCLC) to predict recurrence and overall survival (OS).

A. Madabhushi, V. Velcheti, P. Prasanna, 2018 .

FRMD4A/RET: A Novel RET Oncogenic Fusion Variant in Non-Small Cell Lung Carcinoma.

V. Velcheti, Siraj M. Ali, S. Mukhopadhyay, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Dose–Response Relationship Between Physical Activity and Risk of Heart Failure A Meta-Analysis Epidemiology

C. Ayers, A. Pandey, J. Berry, 2015 .

A man in his 40s with altered mental status, ataxia and unilateral weakness

K. Malhotra, Monica Khunger, T. Scott, 2017, Neuropathology : official journal of the Japanese Society of Neuropathology.

Response.

V. Velcheti, Monica Khunger, Adrian V. Hernández, 2018, Chest.

Incidence of pneumonitis with use of PD-1 and PD-L1 inhibitors in non-small cell lung cancer: A systematic review and meta-analysis of trials.

P. Mazzone, V. Velcheti, N. Pennell, 2017 .

Beyond warfarin: The advent of new oral anticoagulants

K. Malhotra, Monica Khunger, 2016, Indian Journal of Radiology and Imaging.

Non-Vitamin K Oral Anticoagulants in Stroke Patients: Practical Issues

D. Liebeskind, K. Malhotra, Monica Khunger, 2016, Journal of stroke.

Infection in autoimmune bullous diseases: A retrospective comparative study

C. Lohse, Monica Khunger, J. Lehman, 2013, The Journal of dermatology.

Programmed Cell Death 1 (PD-1) Ligand (PD-L1) Expression in Solid Tumors As a Predictive Biomarker of Benefit From PD-1/PD-L1 Axis Inhibitors: A Systematic Review and Meta-Analysis.

K. Schalper, V. Velcheti, S. Mukhopadhyay, 2017, JCO precision oncology.

Dysplasia and cancer screening in 21st century

A. Tiwari, Monica Khunger, H. Roy, 2014, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Programmed Cell Death 1 ( PD-1 ) Ligand ( PD-L 1 ) Expression in Solid Tumors As a Predictive Biomarker of Benefit From PD-1 / PD-L 1 Axis Inhibitors : A Systematic Review and Meta-Analysis

K. Schalper, V. Velcheti, S. Mukhopadhyay, 2017 .

Dabrafenib in combination with trametinib in the treatment of patients with BRAF V600-positive advanced or metastatic non-small cell lung cancer: clinical evidence and experience

V. Velcheti, Monica Khunger, A. Khunger, 2018, Therapeutic advances in respiratory disease.

Premature clinical trial discontinuation in all and genitourinary (GU) cancers in the era of immune checkpoint inhibitors (ICI).

M. Galsky, P. Grivas, S. Rakshit, 2017 .

Post-treatment changes in hematological parameters predict response to nivolumab monotherapy in non-small cell lung cancer patients

V. Velcheti, T. Panchabhai, N. Pennell, 2018, PloS one.

Subcision for depressed facial scars made easy using a simple modification.

Monica Khunger, Niti Khunger, 2011, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Incidence of Thromboembolic Complications Within 30 Days of Electrical Cardioversion Performed Within 48 Hours of Atrial Fibrillation Onset.

M. Chung, P. Tchou, Monica Khunger, 2016, JACC. Clinical electrophysiology.

Incidence of Pneumonitis With Use of Programmed Death 1 and Programmed Death‐Ligand 1 Inhibitors in Non‐Small Cell Lung Cancer: A Systematic Review and Meta‐Analysis of Trials

P. Mazzone, V. Velcheti, N. Pennell, 2017, Chest.

Combination of Peri- and Intratumoral Radiomic Features on Baseline CT Scans Predicts Response to Chemotherapy in Lung Adenocarcinoma.

A. Madabhushi, P. Rajiah, V. Velcheti, 2019, Radiology. Artificial intelligence.

Safety and Efficacy of PD‐1/PD‐L1 Inhibitors in Treatment‐Naive and Chemotherapy‐Refractory Patients With Non–Small‐Cell Lung Cancer: A Systematic Review and Meta‐Analysis

V. Velcheti, N. Pennell, S. Rakshit, 2018, Clinical lung cancer.

Optimal management of hereditary hemorrhagic telangiectasia

Neetika Garg, Arjun Gupta, Nilay Kumar, 2014, Journal of blood medicine.

Dose – Response Relationship Between Physical Activity and Risk of Heart Failure A Meta-Analysis

C. Ayers, A. Pandey, J. D. de Lemos, 2022 .

Evaluation of CROSS technique with 100% TCA in the management of ice pick acne scars in darker skin types

Deepali Bhardwaj, Monica Khunger, Niti Khunger, 2011, Journal of cosmetic dermatology.

Reporting Compliance of Stroke Trials: Cross-Sectional Analysis.

D. Liebeskind, K. Malhotra, A. Rayi, 2017, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Pre-treatment hematological markers as a predictive biomarker for survival in patients with non-small cell lung cancer treated with nivolumab.

V. Velcheti, N. Pennell, P. Elson, 2017 .

Changes in Computer Extracted Features of Vessel Tortuosity on CT Scans Post-Treatment in Responders Compared to Non-Responders for Non–Small Cell Lung Cancer on Immunotherapy

A. Madabhushi, V. Velcheti, R. Thawani, 2017 .

To Treat or Not to Treat: Role of Immunotherapy in Patients with Concomitant Diagnosis of Advanced-Stage Non-Small Cell Lung Cancer and Psoriasis.

V. Velcheti, Monica Khunger, C. Calabrese, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

PD-1/PD-L1 interaction and CD25/FOXP3+ t cells to predict survival benefit from adjuvant chemotherapy in early stage non–small-cell lung cancer (ES-NSCLC).

J. Bordeaux, D. Rimm, K. Schalper, 2018 .

Dose–Response Relationship Between Physical Activity and Risk of Heart Failure: A Meta-Analysis

C. Ayers, A. Pandey, J. D. de Lemos, 2015, Circulation.

A content analysis of smartphone-based applications for hypertension management.

Neetika Garg, Arjun Gupta, Nilay Kumar, 2015, Journal of the American Society of Hypertension : JASH.

Evaluation of CROSS technique with 100% TCA in the management of ice pick acne scars in darker skin types

Deepali Bhardwaj, Monica Khunger, Niti Khunger, 2011, Journal of cosmetic dermatology.

Dose – Response Relationship Between Physical Activity and Risk of Heart Failure A Meta-Analysis

C. Ayers, A. Pandey, J. Berry, 2022 .